🔗 Share this article

Chancellor Reeves has revealed she is planning "focused steps to address household expense challenges" in the upcoming financial statement.

During an interview with the BBC, she emphasized that curbing price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Energy Bill Interventions

Sources suggest the administration could intervene to lower energy bills, for instance by cutting the present 5% level of VAT applied on energy supplies.

A further possibility is to cut some of the regulatory levies currently added to bills.

Fiscal Constraints and Expert Expectations

The administration will obtain the next report from the official forecaster, the OBR, on Monday, which will clarify how much space there is for these measures.

The expectation from the majority of economists is that Reeves will have to announce higher taxes or budget cuts in order to meet her declared fiscal targets.

Previously on the same day, analysis suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of expectations.

"There's a shared job between the Bank of England and the government to further reduce some of the sources of price increases," Reeves stated to the BBC in Washington, at the conferences of the IMF and global financial institution.

Tax Commitments and Global Concerns

While much of the focus has been on expected tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to campaign commitments not to increase tax levels on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with rising international and trade issues for the fiscal revenue measures, likely to be targeted on those "most able to pay."

International Economic Disputes

Addressing concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests always are paramount."

Recent announcement by China to increase trade restrictions on critical minerals and other materials that are crucial for advanced tech manufacturing led US President Donald Trump to threaten an further 100% import tax on goods from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary labeled the Chinese move "economic coercion" and "a international production power grab."

Inquired about accepting the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the world economy and causes additional challenges."

"In my view there are sectors where we must address Chinese policies, but there are also important opportunities to sell into China's economy, including financial services and other areas of the economic system. We've got to achieve that balance appropriate."

The chancellor also affirmed she was cooperating with G7 counterparts "on our own critical minerals approach, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also recognized that the cost the National Health Service spends on pharmaceuticals could increase as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and funding.

Some of the biggest global drug companies have said lately that they are either halting or canceling operations in the United Kingdom, with several blaming the insufficient payments they are getting.

Recently, the Science Minister said the cost the NHS pays for drugs would need to increase to halt firms and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "It has been observed because of the payment system, that medical research, new drugs have not been available in the UK in the extent that they are in other continental states."

"We want to guarantee that people getting treatment from the NHS are can receive the best life-saving drugs in the globe. And so we are reviewing this situation, and... seeking to attract increased funding into Britain."